SUBSCRIBE
SUBSCRIBE
News   Business

Novartis Pharma AG And Chugai Pharmaceutical Co., Ltd. (Japan) To Ship Agent For Postmenopausal Breast Cancer

May 11, 2006 | 
1 min read
Tokyo, May 11, 2006 (JCN) - On May 10, Novartis Pharma and Chugai Pharmaceutical jointly announced that they will release Femara Tablet 2.5mg (letrozole), an agent for the treatment of postmenopausal breast cancer, on May 11.
Alliances Asia
MORE ON THIS TOPIC
Cooperation concept. Vector of a businessman and a businesswoman connecting the bridge with a missing part
GLP-1s
Novo Nordisk Agrees To Sell GLP-1 Drugs Via Hims & Hers, Ending Dispute
March 9, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Dashed line from pills isolated on white
Cancer
Ipsen Pulls Cancer Drug Amid Risk of Secondary Malignancies
March 9, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Vertex Terminates 20 in Reorganization Push
March 9, 2026
 · 
32 min read
 · 
BioSpace Editorial Staff
Brain tumor medical poster. Cancer, metastasis or benign in the human head or in the nerves, pituitary gland, pineal gland, and membranes that cover the surface of the brain 3D vector illustration
Mergers & acquisitions
Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy
March 6, 2026
 · 
1 min read
 · 
Annalee Armstrong